Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome) Latest Advances
Find the Latest Research About Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 995 publications
Growth Patterns in MPS IVA and MPS IIIA: A Longitudinal Single-Center Study.
Journal: Journal of clinical medicine
Published: April 19, 2026
Mapping Sanfilippo Syndrome: A Multisystem Clinicopathological Autopsy.
Journal: Diagnostics (Basel, Switzerland)
Published: March 19, 2026
Molecular Modeling of N-Acetylglucosamine Binding to the I154R Mutant of NAGLU: Pathogenic Insights into Sanfilippo Syndrome Type B.
Journal: International journal of molecular sciences
Published: March 16, 2026
Novel HGSNAT Variants Identified in the Oldest Siblings With MPS IIIC: Functional Characterization and Literature Review.
Journal: American journal of medical genetics. Part A
Published: January 16, 2026
Retinal Phenotype in Mucopolysaccharidosis Type III.
Journal: American journal of ophthalmology
Published: December 29, 2025
Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.
Journal: Biomolecules
Published: December 20, 2025
Sanfilippo syndrome type A with acute metabolic acidosis: a case report of the first documented SGSH c.571G > A homozygous mutation.
Journal: BMC pediatrics
Published: December 01, 2025
Unveiling Mucopolysaccharidosis IIIC in Brazil: Diagnostic Journey and Clinical Features of Brazilian Patients Identified Through the MPS Brazil Network.
Journal: Diseases (Basel, Switzerland)
Published: October 28, 2025
Neuroinflammation as a Novel Therapeutic Frontier for Sanfilippo Syndrome.
Journal: Children (Basel, Switzerland)
Published: October 15, 2025
Mucopolysaccharidosis IIID and Beta-Mannosidosis in Brazilian Anglo-Nubian Goats: Molecular and Genealogical Insights for the Development and Implementation of a Genetic Disease Eradication Program.
Journal: Animal genetics
Published: September 29, 2025
A case of mucopolysaccharidosis type ⅢA with ventricular hypertrophy as the first clinical presentation
Journal: Zhonghua xin xue guan bing za zhi
Published: September 15, 2025
Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice.
Journal: The Journal of clinical investigation
Published: August 28, 2025
Last Updated: 06/30/2026